WEJ

4,5-dimethyl-N-(2-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazole-3-carboxamide

Created:	2020-10-21
Last modified:	2021-07-07

Find Related PDB Entry
1 entries where WEJ is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	42
Chiral Atom Count	0
Bond Count	45
Aromatic Bond Count	21

2D diagram of WEJ

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4,5-dimethyl-N-(2-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazole-3-carboxamide
Systematic Name (OpenEye OEToolkits)	4,5-dimethyl-~{N}-(2-phenyl-1~{H}-pyrrolo[2,3-b]pyridin-5-yl)-1~{H}-pyrazole-3-carboxamide
Formula	C₁₉ H₁₇ N₅ O
Molecular Weight	331.371
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	Cc4c(C)c(C(Nc3cnc2nc(c1ccccc1)cc2c3)=O)nn4
SMILES	CACTVS	3.385	Cc1[nH]nc(C(=O)Nc2cnc3[nH]c(cc3c2)c4ccccc4)c1C
SMILES	OpenEye OEToolkits	2.0.7	Cc1c([nH]nc1C(=O)Nc2cc3cc([nH]c3nc2)c4ccccc4)C
Canonical SMILES	CACTVS	3.385	Cc1[nH]nc(C(=O)Nc2cnc3[nH]c(cc3c2)c4ccccc4)c1C
Canonical SMILES	OpenEye OEToolkits	2.0.7	Cc1c([nH]nc1C(=O)Nc2cc3cc([nH]c3nc2)c4ccccc4)C
InChI	InChI	1.03	InChI=1S/C19H17N5O/c1-11-12(2)23-24-17(11)19(25)21-15-8-14-9-16(22-18(14)20-10-15)13-6-4-3-5-7-13/h3-10H,1-2H3,(H,20,22)(H,21,25)(H,23,24)
InChIKey	InChI	1.03	NVSHVYGIYPBTEZ-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank ID	DB18041
Name	Bezuclastinib
Groups	investigational
Synonyms	3,4-dimethyl-N-(2-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazole-5- carboxamide Bezuclastinib 3,4-dimethyl-n-(2-phenyl-1h-pyrrolo(2,3-b)pyridin-5-yl)-1h-pyrazole-5-carboxamide
CAS number	1616385-51-3

Related Resource References

Resource Name	Reference
PubChem	75593308

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.